Boothbay Fund Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,978
| Closed | -$1.12M | – | 1269 |
|
|
2024
Q4 | $1.12M | Sell |
50,978
-32,424
| -39% | -$714K | 0.03% | 501 |
|
|
2024
Q3 | $1.4M | Buy |
83,402
+35,106
| +73% | +$591K | 0.03% | 532 |
|
|
2024
Q2 | $577K | Buy |
48,296
+35,048
| +265% | +$419K | 0.01% | 818 |
|
|
2024
Q1 | $147K | Buy |
+13,248
| New | +$147K | ﹤0.01% | 1205 |
|
|
2023
Q4 | – | Sell |
-56,623
| Closed | -$433K | – | 1514 |
|
|
2023
Q3 | $433K | Buy |
+56,623
| New | +$433K | 0.01% | 916 |
|